News

For patients with kidney failure, the ability to replace a damaged kidney with a healthy kidney grown from their own cells could be a life saver. Now, AIBN scientists have developed a remarkable new research tool that could help make this a reality.  

AIBN researchers could use a process developed to fight Hendra virus to help manufacture treatments for other potentially deadly disease.

UQ researchers in the AIBN labs have been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new technology.

Judges make their final decisions for creative and ingenious Stem Cell Hackathon.

A new generation of indigenous Australian data scientists may soon take the research world by storm thanks to new funding to a high school student program.

PhD student Caizhi Liao has overcome more than 40 entries to claim first prize in the 2019 AIBN Science Image Contest.

Professor Lianzhou Wang and Professor Yusuke Yamauchi have been named among the world’s most influential minds for this year’s Highly Cited Research list.

An antibody that could treat immune system disorders could be on the path to clinical trials after securing $20 million in Series A funding.

AIBN's Dr Nasim Amiralian is leading a project on developing a new generation of sustainable composite materials designed specifically for electric vehicles.

Dr Hang Ta has received funding from the Heart Foundation for her research into how nanomedicines could detect and treat heart disease.

AIBN Professor Yusuke Yamauchi has been named as one of Australia’s Top 40 Researchers in a special ‘Stars of Research’ report published by The Australian.

A clinical trial for motor neurone disease (MND) patients will proceed thanks to a funding boost from FightMND.

Cutting-edge research at the Australian Institute of Bioengineering and Nanotechnology has won Australia’s most prestigious awards.

Three Early Career Researchers at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) have been awarded nearly $2 million in Investigator Grants from the National Health and Medical Research Council (NHMRC).

At AIBN, we are always happy to hear about the bright paths being forged by former students and researchers, which is why we’re very excited by recent news about former AIBN Honours student Dr James Briggs.

A facility headquartered at AIBN has received $4.59 million from the Queensland Government to continue its innovative research and industry projects such as needle-free vaccine delivery.

AIBN's Associate Professor Claudia Vickers has been been named as one of the Australian Financial Review’s Boss Magazine’s True Leaders of 2019.

An Australian gold mining company will aid the development of a rapid cancer test with a $300,000 donation to AIBN.

AIBN would like to extend a warm congratulations to the Spinifex Nanocellulose Pilot Plant Team at Long Pocket for winning a 2019 University of Queensland Excellence Award for Leadership.

Professor Debra Bernhardt, best known in the scientific world for her contribution to deriving the Evans-Searles Fluctuation Theorem, was elected a Fellow of the Australian Academy of Science.